Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study

Journal of Investigational Allergology and Clinical Immunology

Volumn 8, Issue 3, 1998, Pages 165-171

  Horak, F ^a,b   Stubner P ^a   Berger, U E ^a   Marks, B ^a   Toth, J ^a   Jager S ^a  

^a University Eye Clinic   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Birch pollen; Challenge test; Placebo controlled study; Sublingual immunotherapy; Vienna challenge chamber (VCC)

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PLACEBO; POLLEN EXTRACT;

ADULT; ARTICLE; BRONCHUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MAINTENANCE THERAPY; MALE; NOSE SECRETION; PATIENT; PRICK TEST; PROVOCATION TEST; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; RHINOMANOMETRY; SKIN MANIFESTATION; SOMNOLENCE; STOMACH PAIN; SUBLINGUAL DRUG ADMINISTRATION; URTICARIA;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ALLERGENS; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; POLLEN; RESPIRATORY HYPERSENSITIVITY; RHINITIS, ALLERGIC, SEASONAL; SKIN TESTS;

EID: 0031877188     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Eriksson, N.E., Wihl, J.A., Arrendal, H., Strandhede, S.O. Tree pollen allergy. III. Cross reactions based on results from skin prick tests and the RAST in hayfever patients A multi-centre study. J Allergy 1987, 42 (3): 205-14.
2. Gluck, U. Neglected allergens. Ther Umsch 1992, 49 (10): 669-73.
3. EAACI Immunotherapy Subcommittee. Immunotherapy position paper. Allergy 1993, 48 (Suppl. 14): 9-35.
4. Taudorf, E., Laursen, L., Lanner, A., Bjorksten, B., Dreborg, S., Soborg, M., Weeke, B. Oral immunotherapy in birch pollen hay fever. J Allergy Clin Immunol 1987, 80: 153-61.
5. Moller, C., Dreborg, S., Lanner, A., Bjorgsten, B. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. Allergy 1986, 41: 280-5.
6. Nickelsen, J., Goldstein, S., Müller, U., Wypych, J., Reisman, R., Arbesman, C. Local intranasal immunotherapy for ragweed allergic rhinitis. Clinical response. J Allergy Clin Immunol 1981, 68: 33-40.
7. Mathews, K., Bayne, N., Banas, J., McLean, J., Bacon, J. Controlled studies of intranasal immunotherapy for ragweed pollinosis. Int Archs Allergy Appl Immunol 1981, 66: 218-24.
8. Scadding, G., Brostoff, J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy 1986, 16: 483-91.
9. Van Niekerk, C., Wet, J. Efficacy of grass-maize pollen oral immunetherapy in patients with seasonal hay-fever A double-blind study. Clin Allergy 1987, 17: 507-13.
10. Tan, M., Mancino, M., Monti, G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study. Allergol Immunopathol 1990, 18: 277-84.
11. Almagro E., Asensio, O., Bartolome, J.M., Bosque, M., de la Hoz, B., Dolz, I., Elorza, J., Ferreiro, M., Garcia, J.M., Losada, E., Luna, I., Madrazo, J.L., Malek, T., Marco, T., Mariscal, J., Meseguer, J., Nieto, A., Olivé, A., Pérez-Francés, C., Sánchez-Cano, M., Sastre, A., Tejedor, M.A., de la Torre, F. Multicenter drug surveillance of sub-lingual immunotherapy in allergic patients. Allergol Immunopathol Madr 1995, 23 (4): 153-9.
12. Sabbah, A., Hassoun, S., Le Sellin, J., Andre, C., Sicard, H. A double-blind, placebo-controlled trial by the sublingual route of immunetherapy with a standardized grass pollen extract. Allergy 1994, 49 (5): 309-13.
13. Piazza, I., Bizzaro, N. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoldes pteronissinus. Ann Allergy 1993, 71 (5): 461-9.
14. Nelson, H.S., Oppenheimer, J., Vatsia, G.A., Buchmeier, A. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with a standardized cat extract. AJ Allergy Clin Immunol 1993, 92 (2): 229-36.
15. Horak, F., Jäger, S. The Vienna challenge chamber: A new method to test allergen exposition Wiener Klin Woschr 1988, 99 (14): 509-10.
16. Lombardero, M., Gonzalez, R., Duffort, O., Juan, F., Ayuso, R., Ventas, P., Cortés, C., Carreira, J. Evaluación de la actividad biológica total y composición alergénica de extrados alergénicos. Allergol Immunopathol 1986, 14: 189-98.
17. EAACI Subcommittee on Skin Tests. Skin tests used it Type I allergy testing. Position paper. Allergy 1989, 44 (Suppl. 10): 11-59.
18. Pipkom, V. Pharmacological influence of antiallergic medication on in-vivo allergen testing. Allergy 1988, 43: 81-6.
19. Martin, D., Cuesta, P., Rico, P., Cortes, C. A program to analyse cutaneous response by means of parallel line assay. Allergy 1992, 124: 124 (Abst).
20. Bachert, C., Feldmeth, B. Die computerunterstützte Rhinomanometrie (CAR). HNO 1988, 36: 277-81.
21. Sánchez Madrid, F., Morago, G., Corbi, A., Carreira, J. Monoclonal antibodies to three distinct epitopes on human IgE: Their use for determination of allergen specific IgE. J Immunol Methods 1984, 73: 367-78.
22. Morago, G., Carreira, J., Corbi, A., Sánchez Madrid, F. Preparación de anticuerpos monoclonales frente a IgG e IgE humanas y su utilización como réactives en diagnóstico de enfermedades alérgicas. Immunologia 1985, 4: 111-8.
23. 4 quantitation. Int Arch Allergy Appl Immunol 1990, 92: 151-182.
24. Walker, S.R., Rosser, R.M. Quality of life: Assessment and application. Ciba Found Symp 1987, 169-78.
25. Bousquet, J., Bullinger, M., Fayol, C., Marquis, P., Valentin, B., Burtin, B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. JACI 1994, 94: 182-8.
26. Bousquet, J., Duchateau, J., Pignat, J.C., Fayol, C., Marquis, P., Mariz, S., Ware, J.E., Valentin, B., Burtin, B. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. JACI 1996, 98 (2): 309-16.
27. Spaeth, J., Klinek, L., Mösges, R. Sedation in allergic rhinitis is caused by the condition and not by antihistamine treatment. Allergy 1996, 51: 893-906.
28. Howarth, PH. Allergic rhinitis: A rational choice of treatment Resp Med 1989, 83: 179-88.
29. Simons, F.E.R. H1-receptor antagonists. Comparative tolerability and safety. Drug Safety 1994, 10 (5): 350-80.
30. Passalacqua, G., Bousquet, J., Bachert, C., Church, M.K., Bindsley-Jensen, C., Nagy, L., Szemere, P., Davies, R.J., Durham, S.R., Horak. K., Kontou-Fili, K., Malling, H.J., van-Cauwenberge, P., Canonica, G.W. Position paper The clinical safety of H1-receptor antagonists. Allergy 1996, 51: 666-75.
31. Hindmarch, I. Psychometric aspects of antihistamines. Allergy 1995, 50 (Suppl. 24): 48-54.